Bellevue, Washington Clinical Trials

*Healthy Children Studies

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Aneurysm

Overlake Hospital Medical Center

Patients are needed to participate in a clinical research study of Penumbra Coil (PC) 400 to evaluate Intracranial Aneurysms

Angina

Research Site

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Anterior Uveitis

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with Attention Deficit-Hyperactivity Disorder (ADHD)

Autism

Northwest Clinical Research Center

A PHASE II MULTI-CENTER, RANDOMIZED, DOUBLEBLIND, 24-WEEK, 3-ARM, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RO5285119 IN CHILDREN AND ADOLESCENTS AGE 5-17 WITH AUTISM SPECTRUM DISORDER (ASD)

Bipolar Disorder

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION

View More »

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Breast Cancer

Overlake Medical Center

A clinical trial to evaluate treatments using BLZ-100 for patients with Solid Tumors

OverlakMedical Centere

A clinical research study of paclitaxel, Reparixin and placebo for the treatment of Metastatic Breast Cancer, Triple-Negative Breast Cancer

Chronic Back Pain

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Chronic Pain

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

View More »

Research Site

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Northwest Clinical Research Center

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center

A clinical trial to evaluate treatments for patients with Low Back Pain, Chronic

Washington Center for Pain Management

A clinical trial to evaluate treatments for patients with Low Back Pain, Chronic

Constipation

Synergy Pharmaceuticals Inc.

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

COPD (Chronic Obstructive Pulmonary Disease)

Northwest Clinical Research Center

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®, as an Active Control, on Lung Function over a 24-Week Treatment Period in Subjects With Moderate to Very Severe COPD

View More »

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Depression

MMG

Does Your Child Have Depression?

View More »

Research Site Updated

A clinical trial to evaluate treatments using AXS-05 and Bupropion for patients with Treatment Resistant Major Depressive Disorder

Forest Investigative Site 001

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Investigative Site 001

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Depression (Adolescent)

MMG

Does Your Child Have Depression?

Northwest Clinical Research Center

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Depression (Major/Severe)

MMG

Does Your Child Have Depression?

Depression (Pediatric)

Northwest Clinical Research Center

A Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder

Depression (Treatment-Resistant)

Northwest Clinical Research Center

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Northwest Clinical Research Center

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Diabetes (Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Call for Information (Investigational Site 2328)

A clinical trial to evaluate treatments for patients with Type 2 Diabetes Mellitus

Investigational Site Number 8400093

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Diabetic Macular Edema

Research Site

Patients are needed to participate in a clinical research study evaluating REGN910-3 and Intravitreal Aflibercept Injection (IAI) for the treatment of Diabetic Macular Edema

Fibromyalgia

Northwest Clinical Research Center

A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SAFETY STUDY OF DS-5565 FOR TREATMENT OF PAIN DUE TO FIBROMYALGIA IN SUBJECTS WITH CHRONIC KIDNEY DISEASE

Glaucoma

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Specialty Eye Care

A clinical trial to evaluate treatments using Glaucoma Surgery and InnFocus MicroShunt for patients with Primary Open Angle Glaucoma

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Heart Disease

Research Site

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hemodialysis

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Hemorrhage

Lake Washington Vascular

A clinical research study of CELSTAT and Surgicel Original for the treatment of Bleeding Active

Hernia

Overlake Hospital

A clinical study for patients with Hernia, Ventral or Incisional Hernia

High Blood Pressure (Hypertension)

Northwest Clinical Research Center

Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential hypertension (grade 1 and 2)

View More »

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study of Endothelin Receptor Antagonist (ERA), Lisinopril and Placebo to evaluate Essential Hypertension

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Inflammatory Bowel Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Kidney Disease

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Lung Disease

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Lymphocytic Leukemia, Chronic

Swedish - Bellevue

Clinical trial for Patients with Chronic Lymphocytic Leukemia

Macular Degeneration

Research Site

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Research Site

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Research Site

A Phase 3 clinical study for patients with Geographic Atrophy

Vitreoretinal Associates of Washington Updated

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Macular Edema

Research Site

Patients are needed to participate in a clinical research study evaluating REGN910-3 and Intravitreal Aflibercept Injection (IAI) for the treatment of Diabetic Macular Edema

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Migraine and Cluster Headaches

Northwest Clinical Research Center

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE

Northwest Clinical Research Center

A Parallel Group Double-Blind Randomized Placebo Controlled Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Frequent Episodic Migraines

Northwest Clinical Research Center

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Northwest Clinical Research Center

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Chronic Migraine – the REGAIN Study

Neoplasm Metastasis

1160.189.10237 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Ocular Hypertension

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Osteoarthritis

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

View More »

Northwest Clinical Research Center

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study of Investigational Medical Product (IMP) administered in parent study to evaluate Osteoarthritis

Northwest Clinical Research Center

A clinical trial to evaluate treatments using Placebo, Tanezumab 2.5 mg and Tanezumab 2.5mg/5mg for patients with Osteoarthritis, Knee or Osteoarthritis, Hip

Pain

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Posterior Uveitis

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Postherpetic Neuralgia

Northwest Clinical Research Center

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (4% and 8% w/w Ointment) in Patients with Postherpetic Neuralgia

View More »

Teva Investigational Site 13081

A clinical trial to evaluate treatments using TV-45070 and Placebo for patients with Postherpetic Neuralgia (PHN)

Schizophrenia and Schizoaffective Disorders

Northwest Clinical Research Center

A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults with Schizophrenia

Northwest Clinical Research Center

A 12 WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-04958242 IN SUBJECTS WITH COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA (CIAS)

Northwest Clinical Research Center

A phase II randomised, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with Schizophrenia

View More »

Alkermes Investigational Site

Patients are needed to participate in a clinical research study of ALKS 3831 and Olanzapine to evaluate Schizophrenia

Stroke

Research Site

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

1160.189.10237 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Ulcerative Colitis

Research Site

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Research Site

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Research Site

A Phase 3 clinical study for patients with Ulcerative Colitis

Ulcers

Research Site

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Research Site

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Research Site

A Phase 3 clinical study for patients with Ulcerative Colitis

Uveitis

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis